A pharmacokinetics/pharmacodynamics study of sequence specificity of the PARP inhibitor, olaparib (O) with carboplatin (C) in recurrent women's cancers NCT01237067
- Resource Type
- Journal
- Source
CANCER RESEARCH ; APR 15 2012, 72 1p. Supplement: 8- Subject
- Language
- English
- ISSN
- 15387445